Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Biden forges new $475M campaign to drive uptake of Pfizer and Moderna's bivalent Covid vaccines
Endpoints
Tue, 11/22/22 - 04:25 pm
Tags:
COVID-19, vaccines, boosters, bivalent boosters, Joe Biden, Pfizer, Moderna Therapeutics
Pfizer's $1B protein degradation bet yields 3% response rate in Arvinas' midphase breast cancer trial
Fierce Biotech
Tue, 11/22/22 - 11:00 am
Tags:
Pfizer, protein degradation, Arvinas, clinical trials, breast cancer, ARV-471
'I would put us up against mRNA': Novavax sets out vision for vaccine success in COVID and beyond
Fierce Biotech
Fri, 11/18/22 - 11:45 am
Tags:
Novavax, Pfizer, Moderna Therapeutics, vaccines, COVID-19
Pfizer, BioNTech start study testing next COVID-19 vaccine
BioPharma Dive
Thu, 11/17/22 - 11:25 pm
Tags:
Pfizer, BioNTech, vaccines, COVID-19, clinical trials
Pfizer musters J&J, PhRMA's support in closely watched Vyndaqel copay assistance case at Supreme Court
Fierce Pharma
Tue, 11/15/22 - 10:32 am
Tags:
Pfizer, JNJ, copay asssistance programs, kickbacks, Vyndaqel, Vyndamax, Supreme Court
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
BioSpace
Mon, 11/14/22 - 10:59 am
Tags:
biotech, biopharma, employers, corporate culture, Moderna Therapeutics, Genentech, Pfizer, Amgen, AbbVie
Pfizer faces labor action in Australia as workers protest wage increase at manufacturing facility
Endpoints
Wed, 11/9/22 - 11:11 pm
Tags:
Pfizer, Australia, unions, drug manufacturing
Biohaven fuels up for post-Pfizer future with $302M fundraising, fresh faces in the C-suite
Fierce Biotech
Wed, 11/9/22 - 10:41 am
Tags:
Biohaven, Pfizer, funding, epilepsy
Moderna’s Spikevax has higher risk of heart inflammation than Pfizer’s Comirnaty: Study
Medical Marketing and Media
Tue, 11/8/22 - 10:28 pm
Tags:
Pfizer, Moderna Therapeutics, vaccines, COVID-19, myocarditis
Pfizer tops pharma reputation rankings from autoimmune patients
Medical Marketing and Media
Mon, 11/7/22 - 05:21 pm
Tags:
Pfizer, autoimmune disease, reputation
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Drugs.com
Fri, 11/4/22 - 11:03 am
Tags:
Pfizer, elranatamab, FDA, breakthrough therapy, relapsed or refractory multiple myeloma
Pfizer, BioNTech start COVID-flu combination vaccine study
Reuters
Thu, 11/3/22 - 07:33 pm
Tags:
Pfizer, BioNTech, vaccines, Flu, COVID-19, clinical trials
With FDA decision penciled in for May, GSK powers ahead in RSV race with Pfizer
Fierce Biotech
Wed, 11/2/22 - 10:25 am
Tags:
GSK, Pfizer, RSV, vaccines, FDA
FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases
Fierce Pharma
Wed, 11/2/22 - 10:18 am
Tags:
Pfizer, Paxlovid, antivirals, COVID-19, FDA, Robert Califf
After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year
CNN
Tue, 11/1/22 - 12:12 pm
Tags:
Pfizer, vaccines, RSV, maternal vaccines, clinical trials, FDA
Pfizer discards eczema, NASH and breast cancer programs in early-phase clean-out
Fierce Biotech
Tue, 11/1/22 - 12:09 pm
Tags:
Pfizer, R&D, NASH, breast cancer, eczema
Eli Lilly revenue inches up 2%, Pfizer raises full year outlook
Medical Marketing and Media
Tue, 11/1/22 - 11:02 am
Tags:
Eli Lilly, Pfizer, earnings
Pfizer under Italian finance probe over alleged $1.2B profits offshoring
Fierce Pharma
Thu, 10/27/22 - 08:16 pm
Tags:
Pfizer, Italy, taxes, offshoring
After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win
Endpoints
Mon, 10/24/22 - 11:19 am
Tags:
Vaxcyte, vaccines, VAX-24, pneumococcal disease, Pfizer, Prevnar 20, clinical trials
Pfizer blueprints €1B site in Ireland as industry's local investment spree rolls on: report
Fierce Pharma
Mon, 10/24/22 - 11:13 am
Tags:
Pfizer, Ireland, drug manufacturing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.